NEU 2.13% $14.25 neuren pharmaceuticals limited

That's a wild P/E estimate. How do you get that?Current...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,764 Posts.
    lightbulb Created with Sketch. 2353
    That's a wild P/E estimate. How do you get that?

    Current projected earnings are going to be around $85 to $90mil AUD this year after these disappointing results.

    Shares on issue 127mil. That gives EPS of about 71 cents. P/E on $17 is 24.

    Their earnings are expected to decline on these results over the next 12 months, at best flat. Some serious revisions will be coming.

    Given they can't point to any reason for their earnigns to grow, I can't see why the share price doesn't fall by at least 30% to reflect this risk. Angelman is the only thing that could save them at this point.

    Seems like the short report was bang on the money, there is very limited to no growth in daybue. Looks like a total dud.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.